News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Solana rebounds from $119 support – But can SOL push higher?
AMBCrypto·2025/12/29 22:03
HYPE Coin Surges as Avalanche Faces Downward Struggles
Cointurk·2025/12/29 21:03
Crypto Crystal Ball 2026: Will Crypto Lose the Fight for a Market Structure Bill?
Decrypt·2025/12/29 21:01
Bitcoin and Ethereum’s post-Christmas bounce fades as sentiment normalises
AMBCrypto·2025/12/29 20:54
Can Toncoin break above $1.705 and extend its rally? Examining…
AMBCrypto·2025/12/29 20:03
Despite All The Positive Developments, Why Has the Expected “Trump Rally” in Bitcoin Not Happened This Year?
BitcoinSistemi·2025/12/29 19:30
Crypto Stabilization 2025: Cantor Fitzgerald Predicts Resilient Growth Amid Market Volatility
Bitcoinworld·2025/12/29 19:21
Bitcoin Investment Returns: Peter Schiff’s Shocking 3% Annual Yield Revelation for 5-Year Strategy
Bitcoinworld·2025/12/29 19:21
Bitcoin Price Movements: The Revealing Truth Behind Recent ‘Heartbeat Trades’ and Tax Strategy
Bitcoinworld·2025/12/29 19:21
Cangoo Investment: Strategic $10.5M Boost from Major Shareholder Fortifies Bitcoin Mining Giant
Bitcoinworld·2025/12/29 19:21
Flash
12:56
Spot Gold Drops $14 in Short-Term Spot gold has fallen $14 in the short term, declining over 1.00% during the day, currently reported at $4133.10 per ounce. (Jin Shi)
12:52
Splash Beverage Group Inc. has successfully secured a $1 million strategic investment from C/M Capital Partners.This funding will be specifically allocated for the development of its Cannepil project.
12:51
Vivos (OTC market code: RDGL) has received Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) and will initiate a human clinical feasibility study of its Radiogel® Precision Radionuclide Therapy™.This approval marks a key step forward for the clinical application of this innovative therapy, allowing the company to begin initial safety and feasibility assessments in humans. The Radiogel® technology is designed to enable precise radiation treatment within tumors and is expected to provide a new treatment option for cancer patients. The approved clinical study will collect essential data to lay the foundation for larger-scale clinical trials in the future.
News